FIGS, Inc. (NYSE:FIGS – Get Free Report) insider Heather Hasson sold 22,874 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $10.56, for a total transaction of $241,549.44. Following the completion of the transaction, the insider owned 1,251,967 shares in the company, valued at approximately $13,220,771.52. This represents a 1.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
FIGS Trading Down 0.2%
FIGS stock traded down $0.02 during trading on Monday, hitting $10.72. The company had a trading volume of 1,058,586 shares, compared to its average volume of 2,180,712. The stock has a market cap of $1.76 billion, a price-to-earnings ratio of 107.20 and a beta of 1.29. FIGS, Inc. has a 1-year low of $3.57 and a 1-year high of $12.50. The company’s 50 day simple moving average is $11.51 and its 200-day simple moving average is $8.93.
FIGS (NYSE:FIGS – Get Free Report) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. FIGS had a return on equity of 4.50% and a net margin of 3.03%.The business had revenue of $151.66 million during the quarter, compared to analyst estimates of $142.39 million. During the same period last year, the business posted ($0.01) earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. As a group, analysts forecast that FIGS, Inc. will post 0.01 earnings per share for the current fiscal year.
Institutional Investors Weigh In On FIGS
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on FIGS. Morgan Stanley lifted their price objective on shares of FIGS from $7.50 to $8.00 and gave the company an “equal weight” rating in a report on Tuesday, January 13th. Wolfe Research raised FIGS to a “buy” rating in a research report on Wednesday, December 10th. Wall Street Zen upgraded FIGS from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 17th. Telsey Advisory Group reissued a “market perform” rating and set a $9.00 target price (up from $7.00) on shares of FIGS in a research note on Monday, November 3rd. Finally, Barclays increased their price target on FIGS from $9.00 to $11.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, FIGS currently has a consensus rating of “Hold” and an average price target of $10.10.
Get Our Latest Stock Analysis on FIGS
About FIGS
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
See Also
- Five stocks we like better than FIGS
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
